Privileged Code Execution Vulnerability Affects Omnivise T3000 Products
CVE-2024-38876

8.5HIGH

Key Information:

Vendor

Siemens
Status
Omnivise T3000 Application Server R9.2
Omnivise T3000 Domain Controller R9.2
Omnivise T3000 Product Data Management (pdm) R9.2
Omnivise T3000 R8.2 Sp3
Vendor
CVE Published:
2 August 2024

What is CVE-2024-38876?

A vulnerability has been identified in various versions of Siemens Omnivise T3000 applications that permits the regular execution of user-modifiable code with privileged user access. This poses significant security risks, as it allows local authenticated attackers to leverage this flaw to execute arbitrary code with elevated privileges, potentially compromising the integrity and security of affected systems.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Omnivise T3000 Application Server R9.2 0

Omnivise T3000 Domain Controller R9.2 0

Omnivise T3000 Product Data Management (PDM) R9.2 0

References

https://cert-portal.siemens.com/productcert/html/ssa-8573...

CVSS V4

Score:
8.5
Severity:
HIGH
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Local
Attack Complexity:
Low
Attack Required:
None
Privileges Required:
Undefined
User Interaction:
None

Timeline

  • Vulnerability published

JSON
.